About Grifols
Grifols is a company based in Barcelona (Spain) founded in 1909.. The company has 23,830 employees as of December 31, 2024. Grifols has completed 8 acquisitions, including Alkahest, Araclon and Biotest. Grifols operates in a competitive market with competitors including Biogen, UCB, Kymeratx, PureTech Health and Generate Biomedicines, among others.
- Headquarter Barcelona, Spain
- Employees 23830 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Grifols, S.A. Class A
-
Annual Revenue
$7.49 B (USD)9.41as on Dec 31, 2024
-
Net Profit
$163.02 M (USD)270.81as on Dec 31, 2024
-
EBITDA
$1.62 B (USD)37.41as on Dec 31, 2024
-
Latest Funding Round
$21 M (USD), Grant
Jan 15, 2025
- Investors
-
Employee Count
23830
as on Dec 31, 2024
-
Investments & Acquisitions
Alkahest
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Grifols
Grifols is a publicly listed company on the BME with ticker symbol GRF in Spain, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Sales and Marketing
56 people
Leadership Team
54 people
Software Development Team
22 people
Senior Team
13 people
Product Management Team
12 people
Medical Team
10 people
Data Analysis and Operations Team
7 people
Operations Team
5 people
Unlock access to complete
Funding Insights of Grifols
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $21.0M
-
First Round
First Round
(15 Jan 2025)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Grant - Grifols | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Grifols
Grifols has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include The Michael J. Fox Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research for Parkinson's disease is funded by the foundation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Grifols
Grifols has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Alkahest, Araclon and Biotest. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies derived from blood to treat neurological diseases.
|
2014 | ||||
|
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
2011 | ||||
|
Robotic automation for compounding intravenous treatments is provided.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Grifols
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Grifols Comparisons
Competitors of Grifols
Grifols operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, UCB, Kymeratx, PureTech Health and Generate Biomedicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Grifols
Frequently Asked Questions about Grifols
When was Grifols founded?
Grifols was founded in 1909 and raised its 1st funding round 116 years after it was founded.
Where is Grifols located?
Grifols is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Who is the current CEO of Grifols?
Raimon Grifols Roura is the current CEO of Grifols.
How many employees does Grifols have?
As of Dec 31, 2024, the latest employee count at Grifols is 23,830.
What is the annual revenue of Grifols?
Annual revenue of Grifols is $7.49B as on Dec 31, 2024.
What does Grifols do?
Grifols was founded in 1909 in Barcelona, Spain, and operates in the biopharmaceutical sector. Plasma-derived medicines and transfusion medicines are produced for therapeutic areas including neurology, immunology, hepatology, intensive care, pulmonology, hematology, and infectious diseases. Operations focus on treating a broad range of conditions through these specialized therapies, with global reach from its European base.
Who are the top competitors of Grifols?
Grifols's top competitors include ADMA Biologics, BioNTech and Generate Biomedicines.
Is Grifols publicly traded?
Yes, Grifols is publicly traded on BME under the ticker symbol GRF.
How many acquisitions has Grifols made?
Who are Grifols's investors?
Grifols has 1 investor. Key investors include The Michael J. Fox Foundation.
What is Grifols's ticker symbol?
The ticker symbol of Grifols is GRF on BME.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.